Back
Mirati Therapeutics Stock Predictions

A 100% Win Rate In 2022
Click to see this exclusive sit-down interview
Sell
13
MRTX
Mirati Therapeutics
Last Price:
39.07
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7

Kiyosaki WARNS: the economy is the 'biggest bubble' in history
Ready to dump your paper assets? Get Your Free Gold & Silver Guide NowMirati Therapeutics Stock Forecast
- Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 66.8% based on the past 9 years of stock performance.
- Mirati Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Mirati Therapeutics Stock Undervalued?
The current Mirati Therapeutics [MRTX] share price is $39.10. The Score for MRTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal. - MRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Mirati Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 66.8% based on the past 9 years of stock performance.
Mirati Therapeutics Stock Rating
Sell
13
Mirati Therapeutics (MRTX)
is a Sell
Is Mirati Therapeutics overpriced?
- Mirati Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Mirati Therapeutics Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
mirati.com
52-Week Data
52-Week High:
101.30
52-Week Low:
32.96
Prediction Charts
Market Cap:
2.27B
Price in USD:
39.10
Volume:
1.12M
Beta:
1.25
Technical Analysis
SMA50:
45.90
SMA100:
53.26
SMA200:
61.90
52-Wk Change:
-52.42%
Stock Predictions
-
Is Mirati Therapeutics stock public?
Yes, Mirati Therapeutics is a publicly traded company. -
What is the Mirati Therapeutics stock quote today?
The Mirati Therapeutics stock price is 39.10 USD today. -
How to buy Mirati Therapeutics stock online?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-7 | 41.61 | 41.78 | 42.64 | 41.12 |
Mar-8 | 41.54 | 41.67 | 41.92 | 41.08 |
Mar-9 | 41.67 | 40.75 | 42.43 | 40.39 |
Mar-10 | 40.86 | 39.22 | 40.86 | 38.40 |
Mar-13 | 38.95 | 39.08 | 40.09 | 38.53 |
Mar-14 | 40.23 | 44.40 | 44.42 | 39.73 |
Mar-15 | 44.13 | 43.15 | 45.91 | 41.15 |
Mar-16 | 42.88 | 42.87 | 43.38 | 41.03 |
Mar-17 | 42.79 | 41.40 | 42.79 | 40.94 |
Mar-20 | 42.08 | 40.53 | 42.08 | 40.37 |
Mar-21 | 40.60 | 40.72 | 41.62 | 40.17 |
Mar-22 | 40.64 | 39.54 | 40.79 | 39.28 |
Mar-23 | 39.99 | 38.77 | 40.39 | 38.12 |
Mar-24 | 38.49 | 39.10 | 39.19 | 36.92 |
Mirati Therapeutics Earnings
Mirati Therapeutics Earnings Report: Per Share Mirati Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Mirati Therapeutics Forecast Revenue Growth
Mirati Therapeutics Stock Analysis: Historical quarterly revenues per share for Mirati Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $2.26 per share.
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.